mavorixafor will improve the level or result of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Watch for adverse consequences of delicate CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor).Use Caution/Monitor. Ethinyl estradiol may perhaps inhibit the clearance of benzodiazepines